Statin use does not affect survival outcomes for ALS patients, so there may be no need to stop taking them after a diagnosis, per a study.

Neurizon Therapeutics Limited (“Neurizon”), a clinical-stage biotech company dedicated to advancing treatments for ...

During the event held by the China Organ Donation Administrative Center in Shenyang, Liaoning province, Zhang was also ...

Pilar Viladas, a bonafide architecture writer and editor, and former AN Best of Design juror, died on March 15 at a ...

As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agency’s ability to ...

A research group led by Gian Gaetano Tartaglia, Principal Investigator at the Italian Institute of Technology (IIT), ...

The U.S. Food and Drug Administration approved treatment for 11 patients with the rare familial ALS caused by mutations in ...

THE COURAGE-ALS clinical trial, evaluating the efficacy of reldesemtiv in slowing disease progression in amyotrophic lateral ...

The first study participant was enrolled in July 2024, and since that time, the consortium has recruited over 300 participants.

ALS, or amyotrophic lateral sclerosis, is a fatal neurodegenerative disease that gradually robs individuals of their ability to walk, talk, eat, and eventually breathe.

Iowa Wild fans have the chance to cheer on their team, possibly score some great Star Wars-themed gear, and support an ...